|
NICE is developing a series of rapid guidelines on the active management of COVID-19 infection.
The first 3 guidelines will cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.
Further guidelines, to be announced in due course, are likely to include: symptom management; patients receiving radiotherapy; and patients with rheumatoid arthritis.
NICE will be making the guidelines available to healthcare providers around the world on its website, so they can see the approach the UK is taking.
For the latest news on the development of COVID-19 guidelines visit our website.
|
